|
시장보고서
상품코드
1807404
세계의 세포 및 유전자 치료 CRO 시장 : 규모, 점유율 및 동향, 업계 분석(치료 유형별, 제조 서비스 유형별, 최종 사용자별, 지역별), 예측(2025-2034년)Cell & Gene Therapy Contract Research Organizations Market Size, Share, Industry Analysis Report By Type of Therapy (Gene Therapy, Cell Therapy), By Type of Manufacturing Service, By End-User, By Region - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research사의 최신 조사에 따르면 세계의 세포 및 유전자 치료 CRO 시장 규모는 2034년까지 122억 9,000만 달러에 이를 전망입니다. 이 조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
세계의 세포 및 유전자 치료 CRO 시장은 첨단 치료 개발의 가속과 복잡한 임상, 규제, 연구개발 프로세스를 극복하기 위한 전문지식에 대한 요구가 높아짐에 따라 현저하게 성장하고 있습니다. 세포 및 유전자 치료 CRO는 초기 단계의 연구나 임상시험 설계부터 약사 신청이나 승인 후의 모니터링에 이르기까지 엔드 투 엔드의 개발 활동을 관리함으로써 바이오 의약품 기업을 지원하는데 있어서 매우 중요합니다.
이 시장은 세포 및 유전자 치료 파이프라인의 급속한 확대, 제약 및 바이오테크놀러지 기업으로부터의 투자 증가, 제품 승인을 가속하는 유리한 규제 경로에 의해 더욱 지원되고 있습니다. 서비스 제공업체는 고급 분석 도구, 확장 가능한 제조 플랫폼 및 통합 서비스 모델을 채택하여 세계 스폰서에 신속한 일정, 품질 향상 및 비용 효율적인 솔루션을 제공합니다.
세포 및 유전자 치료 CRO 시장 : 분석 개요
치료 유형별로는 세포 치료 분야가 2024년 시장을 독점했습니다. 이것은 상용화 제품 수 증가, 임상 파이프라인의 꾸준한 확대, 자가 및 동종요법 접근법의 채택 확대 등이 배경에 있습니다.
제조 서비스 유형별로는 제조 서비스 분야가 2024년 최대 시장 점유율을 차지했습니다. 이것은 바이러스 벡터, 인공 세포 및 기타 첨단 치료 재료의 대규모 생산에 필요한 복잡한 프로세스와 전문 인프라 때문입니다.
세포 및 유전자 치료 모달리티별로는 유전자 치료와 유전자 변형 세포 치료의 전달 시스템으로서의 역할이 확립되어 있기 때문에 바이러스 벡터가 2024년 시장을 선도했습니다.
치료 영역별로는 혈액 악성 종양의 높은 유병률과 고형 종양에 적응 확대가 진행되고 있기 때문에 2024년 시장은 암 영역이 지배적이었습니다.
최종 사용자별로는 후기 개발 단계로 진행되는 임상시험 증가로 인해 바이오 의약품 분야가 2024년에 가장 큰 점유율을 차지했습니다.
북미는 2024년 세계 시장의 대부분의 점유율을 차지했는데, 이는 혁신적인 치료법에 대한 미국 식품의약국(FDA)과 캐나다 보건부(Health Canada)와 같은 기관의 견고한 규제 체계와 신속한 승인 경로에 기인합니다.
아시아태평양은 중국, 일본, 한국, 호주 등 국가에서 생명공학 및 에코시스템의 확대에 견인되어 2024년에 가장 급성장하는 지역 시장으로 부상했습니다.
세계 주요 시장 기업으로는 Allucent, CMED, CMIC Group, Linical Accelovance, Novotech CRO, Pharmalex GmbH, PPD(Thermo Fisher Scientific, Inc.), Precision for Medicine Group LLC, QPS Holdings, LLC, Syngene International Limited 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 분석 방법
제4장 세계의 세포 및 유전자 치료 CRO 시장 인사이트
- 시장 현황
- 세포 및 유전자 치료 CRO 시장 역학
- 성장 촉진요인과 기회
- 유전자 편집 및 맞춤형 치료의 추진을 위한 공적 자금과 민간 자금의 급증
- CRISPR과 CAR-T의 기술 진보에 수반하는 전문적 CRO 기능 수요 증가
- 억제요인과 과제
- 높은 운영 비용과 복잡한 프로토콜
- 성장 촉진요인과 기회
- PESTLE 분석
- 세포 및 유전자 치료 CRO 시장 동향
- 밸류체인 분석
제5장 세계의 세포 및 유전자 치료 CRO 시장 : 치료 유형별
- 주요 분석 결과
- 소개
- 유전자 치료
- 세포 요법
- 줄기세포 요법
- CAR-T 요법
- 기타 세포 요법
제6장 세계의 세포 및 유전자 치료 CRO 시장 : 제조 서비스 유형별
- 주요 분석 결과
- 소개
- 개발 서비스
- 생산 서비스
- 기타 서비스
제7장 세계의 세포 및 유전자 치료 CRO 시장 : 세포 및 유전자 치료 모달리티별
- 주요 분석 결과
- 소개
- 바이러스 벡터
- 비 바이러스 벡터
- CRISPR/Cas9 및 기타 유전자 편집 도구
제8장 세계의 세포 및 유전자 치료 CRO 시장 : 치료 영역별
- 주요 분석 결과
- 소개
- 종양학
- 신경학
- 심혈관계
- 대사 장애
- 기타 치료 영역
제9장 세계의 세포 및 유전자 치료 CRO 시장 : 최종 사용자별
- 주요 분석 결과
- 소개
- 바이오의약품기업
- 학술기관 및 연구기관
- 의약품 개발 및 제조 업무 수탁 기관(CDMO)
제10장 세계의 세포 및 유전자 치료 CRO 시장 : 지역별
- 주요 분석 결과
- 소개
- 세포 및 유전자 치료 CRO 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 치료 유형별(2020-2034년)
- 북미 : 제조 서비스 유형별(2020-2034년)
- 북미 : 세포 및 유전자 치료 모달리티별(2020-2034년)
- 북미 : 치료 영역별(2020-2034년)
- 북미 : 최종 사용자별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 치료 유형별(2020-2034년)
- 유럽 : 제조 서비스 유형별(2020-2034년)
- 유럽 : 세포 및 유전자 치료 모달리티별(2020-2034년)
- 유럽 : 치료 영역별(2020-2034년)
- 유럽 : 최종 사용자별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 치료 유형별(2020-2034년)
- 아시아태평양 : 제조 서비스 유형별(2020-2034년)
- 아시아태평양 : 세포 및 유전자 치료 모달리티별(2020-2034년)
- 아시아태평양 : 치료 영역별(2020-2034년)
- 아시아태평양 : 최종 사용자별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 치료 유형별(2020-2034년)
- 중동 및 아프리카 : 제조 서비스 유형별(2020-2034년)
- 중동 및 아프리카 : 세포 및 유전자 치료 모달리티별(2020-2034년)
- 중동 및 아프리카 : 치료 영역별(2020-2034년)
- 중동 및 아프리카 : 최종 사용자별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 치료유형별(2020-2034년)
- 라틴아메리카 : 제조 서비스 유형별(2020-2034년)
- 라틴아메리카 : 세포 및 유전자 치료 모달리티별(2020-2034년)
- 라틴아메리카 : 치료 영역별(2020-2034년)
- 라틴아메리카 : 최종 사용자별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
제11장 경쟁 구도
- 사업 확대 및 기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제12장 기업 프로파일
- Altasciences
- Allucent
- CMED
- CMIC Group
- ICON plc
- Labcorp Drug Development(Labcorp)
- Linical Accelovance
- Medpace, Inc.
- Novotech CRO
- Pharmalex GmbH
- PPD(Thermo Fisher Scientific, Inc.)
- Precision for Medicine Group LLC
The cell & gene therapy contract research organizations market size is expected to reach USD 12.29 Billion by 2034, according to a new study by Polaris Market Research. The report "Cell & Gene Therapy Contract Research Organizations Market Size, Share, Trends, Industry Analysis Report By Type of Therapy (Gene Therapy, Cell Therapy), By Type of Manufacturing Service, By Cell and Gene Therapy Modality, By Therapeutic Area, and By End-User, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global cell & gene therapy contract research organizations market is significantly growing driven by the accelerating development of advanced therapies and the increasing need for specialized expertise in navigating complex clinical, regulatory, and manufacturing processes. Cell & gene therapy CROs are crucial in supporting biopharmaceutical companies by managing end-to-end development activities, from early-stage research and clinical trial design to regulatory submissions and post-approval monitoring.
The market is further supported by the rapid expansion of cell and gene therapy pipelines, growing investment from pharmaceutical and biotechnology companies, and favorable regulatory pathways that accelerate product approvals. Service providers are increasingly adopting advanced analytical tools, scalable manufacturing platforms, and integrated service models to deliver faster timelines, improved quality, and cost-efficient solutions for sponsors worldwide.
Cell & Gene Therapy Contract Research Organizations Market Report Highlights
Based on type of therapy, the cell therapy segment dominated the market in 2024, driven by the rising number of commercialized products, a steadily expanding clinical pipeline, and the growing adoption of autologous and allogeneic therapeutic approaches.
In terms of type of manufacturing service, the production services segment accounted for the largest market share in 2024, owing to the intricate processes and specialized infrastructure required for the large-scale production of viral vectors, engineered cells, and other advanced therapeutic materials.
Based on cell and gene therapy modality, the viral vectors segment led the market in 2024, attributed to their well-established role as delivery systems for both gene therapies and genetically modified cell therapies.
By therapeutic area, the oncology segment dominated the market in 2024, supported by the high prevalence of hematologic malignancies and the ongoing expansion of therapies into solid tumor indications.
Based on end user, the biopharmaceutical segment held the largest share in 2024, due to the increasing number of clinical trials progressing to late-stage development.
North America accounted for the majority share of the global market in 2024, attributed to robust regulatory frameworks and expedited approval pathways from agencies such as the US Food and Drug Administration (FDA) and Health Canada for innovative therapies.
Asia Pacific emerged as the fastest-growing regional market in 2024, driven by the expanding biotech ecosystems in countries such as China, Japan, South Korea, and Australia.
A few global key market players include Allucent, CMED, CMIC Group, Linical Accelovance, Novotech CRO, Pharmalex GmbH, PPD (Thermo Fisher Scientific, Inc.), Precision for Medicine Group LLC, QPS Holdings, LLC, and Syngene International Limited.
Polaris Market Research has segmented the market report on the basis of type of therapy, type of manufacturing service, cell and gene therapy modality, therapeutic area, and end-user, and region:
By Type of Therapy Outlook (Revenue, USD Billion, 2020-2034)
Gene Therapy
Cell Therapy
Stem Cell Therapy
CAR-T Therapy
Other Cell Therapies
By Type of Manufacturing Service Outlook (Revenue, USD Billion, 2020-2034)
Development Services
Production Services
Other Services
By Cell and Gene Therapy Modality Outlook (Revenue, USD Billion, 2020-2034)
Viral Vectors
Adeno-associated Virus (AAV)
Lentivirus
Adenovirus
Retrovirus
Other Viral Vectors
Non-Viral Vectors
Plasmid DNA
mRNA-based Therapies
CRISPR/Cas9 and Other Gene Editing Tools
By Therapeutic Area Outlook (Revenue, USD Billion, 2020-2034)
Oncology
Neurology
Cardiovascular
Metabolic Disorders
Other Therapeutic Areas
By End-User Outlook (Revenue, USD Billion, 2020-2034)
Biopharmaceutical Companies
Academic and Research Institutions
Contract Development & Manufacturing Organizations (CDMOs)
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Cell & Gene Therapy Contract Research Organizations Market Insights
- 4.1. Cell & Gene Therapy Contract Research Organizations Market - Market Snapshot
- 4.2. Cell & Gene Therapy Contract Research Organizations Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Surge in Public and Private Funding Advancing Gene Editing and Personalized Therapies
- 4.2.1.2. Technological Advancements in CRISPR and CAR-T Driving Demand for Specialized CRO Capabilities
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Operational Costs and Complex Protocols
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Cell & Gene Therapy Contract Research Organizations Market Trends
- 4.6. Value Chain Analysis
5. Global Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 5.3. Gene Therapy
- 5.3.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Gene Therapy, by Region, 2020-2034 (USD Billion)
- 5.4. Cell Therapy
- 5.4.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Cell Therapy, by Region, 2020-2034 (USD Billion)
- 5.5. Stem Cell Therapy
- 5.5.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Stem Cell Therapy, by Region, 2020-2034 (USD Billion)
- 5.6. CAR-T Therapy
- 5.6.1. Global Cell & Gene Therapy Contract Research Organizations Market, by CAR-T Therapy, by Region, 2020-2034 (USD Billion)
- 5.7. Other Cell Therapies
- 5.7.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Other Cell Therapies, by Region, 2020-2034 (USD Billion)
6. Global Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 6.3. Development Services
- 6.3.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Development Services, by Region, 2020-2034 (USD Billion)
- 6.4. Production Services
- 6.4.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Production Services, by Region, 2020-2034 (USD Billion)
- 6.5. Other Services
- 6.5.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Other Services, by Region, 2020-2034 (USD Billion)
7. Global Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 7.3. Viral Vectors
- 7.3.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Viral Vectors, by Region, 2020-2034 (USD Billion)
- 7.3.1.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Adeno-associated Virus (AAV), by Region, 2020-2034 (USD Billion)
- 7.3.1.2. Global Cell & Gene Therapy Contract Research Organizations Market, by Lentivirus, by Region, 2020-2034 (USD Billion)
- 7.3.1.3. Global Cell & Gene Therapy Contract Research Organizations Market, by Adenovirus, by Region, 2020-2034 (USD Billion)
- 7.3.1.4. Global Cell & Gene Therapy Contract Research Organizations Market, by Retrovirus, by Region, 2020-2034 (USD Billion)
- 7.3.1.5. Global Cell & Gene Therapy Contract Research Organizations Market, by Other Viral Vectors, by Region, 2020-2034 (USD Billion)
- 7.3.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Viral Vectors, by Region, 2020-2034 (USD Billion)
- 7.4. Non-Viral Vectors
- 7.4.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Non-Viral Vectors, by Region, 2020-2034 (USD Billion)
- 7.4.1.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Plasmid DNA, by Region, 2020-2034 (USD Billion)
- 7.4.1.2. Global Cell & Gene Therapy Contract Research Organizations Market, by mRNA-based Therapies, by Region, 2020-2034 (USD Billion)
- 7.4.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Non-Viral Vectors, by Region, 2020-2034 (USD Billion)
- 7.5. CRISPR/Cas9 and Other Gene Editing Tools
- 7.5.1. Global Cell & Gene Therapy Contract Research Organizations Market, by CRISPR/Cas9 and Other Gene Editing Tools, by Region, 2020-2034 (USD Billion)
8. Global Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.3. Oncology
- 8.3.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 8.4. Neurology
- 8.4.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Neurology, by Region, 2020-2034 (USD Billion)
- 8.5. Cardiovascular
- 8.5.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
- 8.6. Metabolic Disorders
- 8.6.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Metabolic Disorders, by Region, 2020-2034 (USD Billion)
- 8.7. Other Therapeutic Area
- 8.7.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Other Therapeutic Area, by Region, 2020-2034 (USD Billion)
9. Global Cell & Gene Therapy Contract Research Organizations Market, by End-User
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 9.3. Biopharmaceutical Companies
- 9.3.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
- 9.4. Academic and Research Institutions
- 9.4.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Academic and Research Institutions, by Region, 2020-2034 (USD Billion)
- 9.5. Contract Development & Manufacturing Organizations (CDMOs)
- 9.5.1. Global Cell & Gene Therapy Contract Research Organizations Market, by Contract Development & Manufacturing Organizations (CDMOs), by Region, 2020-2034 (USD Billion)
10. Global Cell & Gene Therapy Contract Research Organizations Market, by Geography
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. Cell & Gene Therapy Contract Research Organizations Market Assessment, By Geography, 2020-2034 (USD Billion)
- 10.3. Cell & Gene Therapy Contract Research Organizations Market - North America
- 10.3.1. North America: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.3.2. North America: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.3.3. North America: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.3.4. North America: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.3.5. North America: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.3.6. Cell & Gene Therapy Contract Research Organizations Market - U.S.
- 10.3.6.1. U.S.: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.3.6.2. U.S.: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.3.6.3. U.S.: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.3.6.4. U.S.: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.3.6.5. U.S.: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.3.7. Cell & Gene Therapy Contract Research Organizations Market - Canada
- 10.3.7.1. Canada: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.3.7.2. Canada: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.3.7.3. Canada: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.3.7.4. Canada: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.3.7.5. Canada: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.4. Cell & Gene Therapy Contract Research Organizations Market - Europe
- 10.4.1. Europe: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.4.2. Europe: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.4.3. Europe: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.4.4. Europe: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.4.5. Europe: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.4.6. Cell & Gene Therapy Contract Research Organizations Market - UK
- 10.4.6.1. UK: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.4.6.2. UK: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.4.6.3. UK: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.4.6.4. UK: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.4.6.5. UK: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.4.7. Cell & Gene Therapy Contract Research Organizations Market - France
- 10.4.7.1. France: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.4.7.2. France: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.4.7.3. France: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.4.7.4. France: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.4.7.5. France: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.4.8. Cell & Gene Therapy Contract Research Organizations Market - Germany
- 10.4.8.1. Germany: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.4.8.2. Germany: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.4.8.3. Germany: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.4.8.4. Germany: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.4.8.5. Germany: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.4.9. Cell & Gene Therapy Contract Research Organizations Market - Italy
- 10.4.9.1. Italy: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.4.9.2. Italy: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.4.9.3. Italy: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.4.9.4. Italy: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.4.9.5. Italy: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.4.10. Cell & Gene Therapy Contract Research Organizations Market - Spain
- 10.4.10.1. Spain: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.4.10.2. Spain: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.4.10.3. Spain: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.4.10.4. Spain: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.4.10.5. Spain: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.4.11. Cell & Gene Therapy Contract Research Organizations Market - Netherlands
- 10.4.11.1. Netherlands: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.4.11.2. Netherlands: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.4.11.3. Netherlands: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.4.11.4. Netherlands: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.4.11.5. Netherlands: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.4.12. Cell & Gene Therapy Contract Research Organizations Market - Russia
- 10.4.12.1. Russia: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.4.12.2. Russia: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.4.12.3. Russia: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.4.12.4. Russia: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.4.12.5. Russia: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.4.13. Cell & Gene Therapy Contract Research Organizations Market - Rest of Europe
- 10.4.13.1. Rest of Europe: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.4.13.2. Rest of Europe: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.4.13.3. Rest of Europe: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.4.13.4. Rest of Europe: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.4.13.5. Rest of Europe: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.5. Cell & Gene Therapy Contract Research Organizations Market - Asia Pacific
- 10.5.1. Asia Pacific: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.5.6. Cell & Gene Therapy Contract Research Organizations Market - China
- 10.5.6.1. China: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.5.6.2. China: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.5.6.3. China: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.5.6.4. China: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.5.6.5. China: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.5.7. Cell & Gene Therapy Contract Research Organizations Market - India
- 10.5.7.1. India: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.5.7.2. India: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.5.7.3. India: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.5.7.4. India: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.5.7.5. India: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.5.8. Cell & Gene Therapy Contract Research Organizations Market - Malaysia
- 10.5.8.1. Malaysia: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.5.8.2. Malaysia: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.5.8.3. Malaysia: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.5.8.4. Malaysia: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.5.8.5. Malaysia: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.5.9. Cell & Gene Therapy Contract Research Organizations Market - Japan
- 10.5.9.1. Japan: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.5.9.2. Japan: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.5.9.3. Japan: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.5.9.4. Japan: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.5.9.5. Japan: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.5.10. Cell & Gene Therapy Contract Research Organizations Market - Indonesia
- 10.5.10.1. Indonesia: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.5.10.2. Indonesia: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.5.10.3. Indonesia: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.5.10.4. Indonesia: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.5.10.5. Indonesia: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.5.11. Cell & Gene Therapy Contract Research Organizations Market - South Korea
- 10.5.11.1. South Korea: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.5.11.2. South Korea: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.5.11.3. South Korea: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.5.11.4. South Korea: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.5.11.5. South Korea: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.5.12. Cell & Gene Therapy Contract Research Organizations Market - Australia
- 10.5.12.1. Australia: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.5.12.2. Australia: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.5.12.3. Australia: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.5.12.4. Australia: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.5.12.5. Australia: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.5.13. Cell & Gene Therapy Contract Research Organizations Market - Rest of Asia Pacific
- 10.5.13.1. Rest of Asia Pacific: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.5.13.2. Rest of Asia Pacific: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.5.13.3. Rest of Asia Pacific: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.5.13.4. Rest of Asia Pacific: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.5.13.5. Rest of Asia Pacific: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.6. Cell & Gene Therapy Contract Research Organizations Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.6.6. Cell & Gene Therapy Contract Research Organizations Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.6.6.2. Saudi Arabia: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.6.6.3. Saudi Arabia: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.6.6.4. Saudi Arabia: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.6.6.5. Saudi Arabia: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.6.7. Cell & Gene Therapy Contract Research Organizations Market - UAE
- 10.6.7.1. UAE: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.6.7.2. UAE: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.6.7.3. UAE: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.6.7.4. UAE: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.6.7.5. UAE: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.6.8. Cell & Gene Therapy Contract Research Organizations Market - Israel
- 10.6.8.1. Israel: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.6.8.2. Israel: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.6.8.3. Israel: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.6.8.4. Israel: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.6.8.5. Israel: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.6.9. Cell & Gene Therapy Contract Research Organizations Market - South Africa
- 10.6.9.1. South Africa: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.6.9.2. South Africa: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.6.9.3. South Africa: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.6.9.4. South Africa: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.6.9.5. South Africa: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.6.10. Cell & Gene Therapy Contract Research Organizations Market - Rest of Middle East & Africa
- 10.6.10.1. Rest of Middle East & Africa: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.6.10.2. Rest of Middle East & Africa: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.6.10.3. Rest of Middle East & Africa: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.6.10.4. Rest of Middle East & Africa: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.6.10.5. Rest of Middle East & Africa: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.7. Cell & Gene Therapy Contract Research Organizations Market - Latin America
- 10.7.1. Latin America: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.7.6. Cell & Gene Therapy Contract Research Organizations Market - Mexico
- 10.7.6.1. Mexico: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.7.6.2. Mexico: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.7.6.3. Mexico: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.7.6.4. Mexico: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.7.6.5. Mexico: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.7.7. Cell & Gene Therapy Contract Research Organizations Market - Brazil
- 10.7.7.1. Brazil: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.7.7.2. Brazil: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.7.7.3. Brazil: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.7.7.4. Brazil: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.7.7.5. Brazil: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.7.8. Cell & Gene Therapy Contract Research Organizations Market - Argentina
- 10.7.8.1. Argentina: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.7.8.2. Argentina: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.7.8.3. Argentina: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.7.8.4. Argentina: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.7.8.5. Argentina: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
- 10.7.9. Cell & Gene Therapy Contract Research Organizations Market - Rest of Latin America
- 10.7.9.1. Rest of Latin America: Cell & Gene Therapy Contract Research Organizations Market, by Type of Therapy, 2020-2034 (USD Billion)
- 10.7.9.2. Rest of Latin America: Cell & Gene Therapy Contract Research Organizations Market, by Type of Manufacturing Service, 2020-2034 (USD Billion)
- 10.7.9.3. Rest of Latin America: Cell & Gene Therapy Contract Research Organizations Market, by Cell and Gene Therapy Modality, 2020-2034 (USD Billion)
- 10.7.9.4. Rest of Latin America: Cell & Gene Therapy Contract Research Organizations Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.7.9.5. Rest of Latin America: Cell & Gene Therapy Contract Research Organizations Market, by End-User, 2020-2034 (USD Billion)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. Altasciences
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Allucent
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. CMED
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. CMIC Group
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. ICON plc
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Labcorp Drug Development (Labcorp)
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. Linical Accelovance
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. Medpace, Inc.
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Novotech CRO
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Pharmalex GmbH
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. PPD (Thermo Fisher Scientific, Inc.)
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. Precision for Medicine Group LLC
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
샘플 요청 목록